General AML

How can precision medicine improve outcomes in older patients with AML?

L: English

During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the AML Global Portal were delighted to speak to the Chief Medical Officer John Byrd, Leukemia and Lymphoma Society, White Plains, US. We asked: How can precision medicine improve outcomes in older patients with acute myeloid leukemia?

John Byrd outlines the benefits of the precision medicine-based approach to treating patients. He discusses the study by Dr Amy Byrd, where patients with AML were allocated treatment according to their genetics and explained those patients had a better outcome compared to patients who received standard of care.